Suppr超能文献

肛门生殖器样本中Anyplex II HPV28与线性阵列HPV基因分型检测之间的人乳头瘤病毒基因型一致性

Human papillomavirus genotype concordance between Anyplex II HPV28 and linear array HPV genotyping test in anogenital samples.

作者信息

Coutlée François, de Pokomandy Alexandra, Burchell Ann N, El-Zein Mariam, Mayrand Marie-Hélène, Rodrigues-Coutlée Sophie, Money Deborah, Comète Émilie, McClymont Elisabeth, Rouleau Danielle, Franco Eduardo L

机构信息

Laboratoire de Virologie Moléculaire, Centre de recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.

Départements de Microbiologie, Infectiologie et Immunologie, et de Gynécologie-Obstétrique, Université de Montréal, Montreal, Quebec, Canada.

出版信息

J Med Virol. 2022 Jun;94(6):2824-2832. doi: 10.1002/jmv.27605. Epub 2022 Jan 28.

Abstract

Anyplex II HPV-28 (HPV-28) can detect individually 28 HPV genotypes. We assessed the agreement between linear array HPV genotyping (LA-HPV) and HPV-28 for detection of 27 HPV genotypes in 410 stored anogenital samples (75 anal samples, 335 physician-collected cervical samples) collected over 5 years from 410 individuals (13 men, 397 women), including 202 HIV-seropositive individuals. HPV DNA was detected in 393 (95.9%, 95% confidence interval [CI]: 93.4-97.4) and 382 (93.2%, 95% CI: 90.3-95.3) samples with HPV-28 and LA-HPV (p = 0.13), respectively, for a good agreement of 96.3% (κ = 0.65). Of the 10503 HPV typing results, 10195 (780 positive, 9577 negative) were concordant, for an agreement of 97.1% (95% CI: 96.7-97.4) and an excellent of κ = 0.82 (95% CI: 0.80-0.84). The mean type-specific concordance for 27 genotypes was 97.0%, 95% CI: 95.8-98.5 (κ = 0.86 ± 0.07, 95% CI: 0.83-0.88). Excellent agreement was obtained individually for all high-risk genotypes (κ = 0.81-0.97) and for most other genotypes except for types 42, 44, 54, 68, and 69. The mean number of types per sample in discordant samples detected with LA-HPV (3.0, 95% CI: 2.7-3.4) was greater than in concordant samples (1.4, 95% CI: 1.3-1.5; p< 0.001). In conclusion, HPV-28 compared favorably with LA-HPV, but was more frequently positive for HPV42 and HPV68.

摘要

Anyplex II HPV-28检测法(HPV-28)能够单独检测28种人乳头瘤病毒(HPV)基因型。我们评估了线性阵列HPV基因分型法(LA-HPV)与HPV-28在检测410份储存的肛门生殖器样本(75份肛门样本,335份医生采集的宫颈样本)中27种HPV基因型的一致性,这些样本是在5年时间里从410名个体(13名男性,397名女性)中采集的,其中包括202名HIV血清阳性个体。分别用HPV-28和LA-HPV在393份(95.9%,95%置信区间[CI]:93.4 - 97.4)和382份(93.2%,95% CI:90.3 - 95.3)样本中检测到了HPV DNA(p = 0.13),一致性良好,为96.3%(κ = 0.65)。在10503份HPV基因分型结果中,10195份(780份阳性,9577份阴性)结果一致,一致性为97.1%(95% CI:96.7 - 97.4),κ值为优秀的0.82(95% CI:0.80 - 0.84)。27种基因型的平均型特异性一致性为97.0%,95% CI:95.8 - 98.5(κ = 0.86 ± 0.07,95% CI:0.83 - 0.88)。所有高危基因型(κ = 0.81 - 0.97)以及除42、44、54、68和69型之外的大多数其他基因型均获得了优秀的一致性。LA-HPV检测到的不一致样本中每个样本的平均基因型数量(3.0,95% CI:2.7 - 3.4)高于一致样本(1.4,95% CI:1.3 - 1.5;p < 0.001)。总之,HPV-28与LA-HPV相比具有优势,但HPV42和HPV68的阳性检出率更高。

相似文献

5
Comparison of Seegene Anyplex II HPV28 assay with BD Onclarity HPV assay for human papillomavirus genotyping.
PLoS One. 2022 Jul 8;17(7):e0267836. doi: 10.1371/journal.pone.0267836. eCollection 2022.
8
Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
J Virol Methods. 2009 Mar;156(1-2):77-83. doi: 10.1016/j.jviromet.2008.11.002. Epub 2008 Dec 17.
9
Comparison of the analytical and clinical performance of five tests for the detection of human papillomavirus genital infection.
J Virol Methods. 2017 Oct;248:238-243. doi: 10.1016/j.jviromet.2017.07.009. Epub 2017 Jul 21.

引用本文的文献

1
Comparative evaluation of Allplex HPV28 and Anyplex II HPV28 assays for high-risk HPV genotyping in cervical samples.
PLoS One. 2025 Apr 1;20(4):e0320978. doi: 10.1371/journal.pone.0320978. eCollection 2025.
2
Prevalence of Human Papillomavirus Genotypes in Unvaccinated 16- to 20-Year-Old Men in Quebec, Canada.
J Infect Dis. 2025 Aug 14;232(2):e203-e212. doi: 10.1093/infdis/jiaf094.
3
Anal human papillomavirus (HPV) disagreement by Linear Array compared to SPF10 PCR-DEIA-LiPA25 system in young sexual minority men.
Heliyon. 2024 Jun 3;10(11):e32336. doi: 10.1016/j.heliyon.2024.e32336. eCollection 2024 Jun 15.

本文引用的文献

1
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing.
J Clin Virol. 2021 Aug;141:104902. doi: 10.1016/j.jcv.2021.104902. Epub 2021 Jun 19.
2
Maternal human papillomavirus infections at mid-pregnancy and delivery in a Scandinavian mother-child cohort study.
Int J Infect Dis. 2021 Jul;108:574-581. doi: 10.1016/j.ijid.2021.05.064. Epub 2021 May 30.
4
The prevalence and risk-factors of oral HPV DNA detection among HIV-infected men between men who have sex with men and heterosexual men.
Infect Dis (Lond). 2021 Jan;53(1):19-30. doi: 10.1080/23744235.2020.1811373. Epub 2020 Sep 11.
5
Effectiveness of bivalent and quadrivalent human papillomavirus vaccination in Luxembourg.
Cancer Epidemiol. 2019 Dec;63:101593. doi: 10.1016/j.canep.2019.101593. Epub 2019 Sep 6.
9
Clinical and Analytical Evaluation of the Anyplex II HPV HR Detection Assay within the VALGENT-3 Framework.
J Clin Microbiol. 2018 Oct 25;56(11). doi: 10.1128/JCM.01176-18. Print 2018 Nov.
10
Impact of HPV vaccination with Gardasil® in Switzerland.
BMC Infect Dis. 2017 Dec 22;17(1):790. doi: 10.1186/s12879-017-2867-x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验